Home
GloBE-Reg is an international registry project whose stakeholders include patients, professionals, scientific organisations and industry.
Its mission includes:-
– Supporting the development of studies with a focus on effectiveness and long-term safety through routine collection of real-world data on specific drugs
– Acting as a longitudinal registry study for effectiveness and long-term safety monitoring for specific drugs where a registry study does not exist
– Working in collaboration with other registries to maximize global knowledge on drug effectiveness and long-term safety
GloBE-Reg Latest News
Drop-in Sessions
Do come to one of our Drop-ins on Friday the 2nd June https://globe-reg.net/drop-in-sessions/
Patient Infosheets – multiple languages
With the help of the GloBE-Reg community, we are building a repository of the GloBE-Reg Patient Information Sheets and Consent Form in multiple languages (https://globe-reg.net/information-sheets/). Contact us (https://globe-reg.net/contact/) if you would like to help.
Somapacitan Study (REAL 10)
Sompacitan Study (REAL10) launches on GloBE-Reg. For further details of the study visit : https://globe-reg.net/somapacitan-study/
GloBE-Reg is supported by GenSci, Novo Nordisk, Pfizer, NHS Research Scotland and the University of Glasgow
Get in Touch
If you would like to find out more please contact info@globe-reg.net.
You can also follow us on Twitter: https://twitter.com/GloBE_Reg.
globe-reg.net 